The inventive subject matter relates to novel methods for modulating an immuneresponse in an animal, which comprises administering to said animal aneffective amount of an agent that increases IL-27R/WSX-1 activity. Further,the inventive subject matter relates to pharmaceutical compositions comprisingan effective amount of an agent that increases IL-27R/WSX-1 activity.